The associations of CD4 count, CD4/CD8 ratio, and HIV viral load with survival from non-small cell lung cancer in persons living with HIV

References

• Agency (Client) Intake Forms. http://www.airsny.org/Forms/v8.9.891/Agency%20Intake%20Forms.zip
   Google Scholar
• Biggar, R. J., Engels, E. A., Ly, S., Kahn, A., Schymura, M. J., Sackoff, J., Virgo, P., & Pfeiffer, R. M. (2005). Survival after cancer diagnosis in persons with AIDS. JAIDS Journal of Acquired Immune Deficiency Syndromes, 39(3), 293–299. https://doi.org/10.1097/01.qai.0000164033.02947.e3
   PubMed Web of Science ®Google Scholar
• Brock, M. V., Hooker, C. M., Engels, E. A., Moore, R. D., Gillison, M. L., Alberg, A. J., Keruly, J. C., Yang, S. C., Heitmiller, R. F., Baylin, S. B., Herman, J. G., & Brahmer, J. R. (2006). Delayed diagnosis and elevated mortality in an urban population with HIV and lung cancer: Implications for patient care. JAIDS Journal of Acquired Immune Deficiency Syndromes, 43(1), 47–55. https://doi.org/10.1097/01.qai.0000232260.95288.93
   PubMed Web of Science ®Google Scholar
• Coghill, A. E., Suneja, G., Rositch, A. F., Shiels, M. S., & Engels, E. A. (2019). HIV Infection, cancer treatment regimens, and cancer outcomes among elderly adults in the United States. JAMA Oncology, 5(9)), e191742. https://doi.org/10.1001/jamaoncol.2019.1742
   PubMed Web of Science ®Google Scholar
• Cook, M. R., & Kim, C. (2019). Safety and efficacy of immune checkpoint inhibitor therapy in patients with HIV Infection and advanced-stage cancer: A systematic review. JAMA Oncology, 5(7), 1049–1054. https://doi.org/10.1001/jamaoncol.2018.6737
   PubMed Web of Science ®Google Scholar
• Diez Roux, A. V., Merkin, S. S., Arnett, D., Chambless, L., Massing, M., Nieto, F. J., Sorlie, P., Szklo, M., Tyroler, H. A., & Watson, R. L. (2001). Neighborhood of residence and incidence of coronary heart disease. New England Journal of Medicine, 345(2), 99–106. https://doi.org/10.1056/nejm200107123450205
   PubMed Web of Science ®Google Scholar
• Felsen, U. R., Bellin, E. Y., Cunningham, C. O., & Zingman, B. S. (2014). Development of an electronic medical record-based algorithm to identify patients with unknown HIV status. AIDS Care, 26(10), 1318–1325. https://doi.org/10.1080/09540121.2014.911813
   PubMed Web of Science ®Google Scholar
• FORDS: Facility Oncology Registry Data Standards Revised for 2016. (2016). https://www.facs.org/~/media/files/quality%20programs/cancer/ncdb/fords%202016.ashx
   Google Scholar
• Hanna, D. B., Felsen, U. R., Ginsberg, M. S., Zingman, B. S., Beil, R. S., Futterman, D. C., Strickler, H. D., & Anastos, K. (2016). Increased antiretroviral therapy use and virologic suppression in the Bronx in the context of multiple HIV prevention strategies. AIDS Research and Human Retroviruses, 32(10-11), 955–963. https://doi.org/10.1089/aid.2015.0345
   PubMed Web of Science ®Google Scholar
• Immunotherapy in Patients With HIV Infection and Advanced Cancer. (2019). https://www.ascopost.com/News/59734
   Google Scholar
• Kirk, G. D., Merlo, C. A., & Lung, H. I. V. S. (2011). HIV infection in the etiology of lung cancer: Confounding, causality, and consequences. Proceedings of the American Thoracic Society, 8(3), 326–332. https://doi.org/10.1513/pats.201009-061WR
   PubMedGoogle Scholar
• Klugman, M., Xue, X., Ginsberg, M., Cheng, H., Rohan, T., & Hosgood 3rd, H. D. (2020). Hispanics/latinos in the Bronx have improved survival in Non-small cell lung cancer compared with Non-Hispanic whites. Journal of Racial and Ethnic Health Disparities, 7(2), 316–326. https://doi.org/10.1007/s40615-019-00660-2
   PubMed Web of Science ®Google Scholar
• Lambert, B. (1989, Feb. 15). AIDS study finds virus at high rate in the Bronx. The New York Times, p. 1.
   Google Scholar
• Lavole, A., Chouaid, C., Baudrin, L., Wislez, M., Raguin, G., Pialoux, G., Girard, P.-M., Milleron, B., & Cadranel, J. (2009). Effect of highly active antiretroviral therapy on survival of HIV infected patients with non-small-cell lung cancer. Lung Cancer, 65(3), 345–350. https://doi.org/10.1016/j.lungcan.2008.11.018
   PubMed Web of Science ®Google Scholar
• Lung Cancer: Screening. (2021). https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/lung-cancer-screening#fullrecommendationstart
   Google Scholar
• Lung Cancer Statistics. https://www.cdc.gov/cancer/lung/statistics/index.htm
   Google Scholar
• Makinson, A., Tenon, J. C., Eymard-Duvernay, S., Pujol, J. L., Allavena, C., Cuzin, L., Poizot-Martin, I., de la Tribonnière, X., Cabié, A., Pugliese, P., Reynes, J., & Le Moing, V. (2011). Human immunodeficiency virus infection and non-small cell lung cancer: Survival and toxicity of antineoplastic chemotherapy in a cohort study. Journal of Thoracic Oncology, 6(6), 1022–1029. https://doi.org/10.1097/JTO.0b013e318217b6e0
   PubMed Web of Science ®Google Scholar
• Molina, J. R., Yang, P., Cassivi, S. D., Schild, S. E., & Adjei, A. A. (2008). Non-small cell lung cancer: Epidemiology, risk factors, treatment, and survivorship. Mayo Clinic Proceedings, 83(5), 584–594. https://doi.org/10.4065/83.5.584
   PubMed Web of Science ®Google Scholar
• New York City Annual HIV/AIDS Surveillance Statistics 2019. (2020). https://www1.nyc.gov/assets/doh/downloads/pdf/ah/surveillance2019-tables-all.pdf
   Google Scholar
• Park, L. S., Hernandez-Ramirez, R. U., Silverberg, M. J., Crothers, K., & Dubrow, R. (2016). Prevalence of non-HIV cancer risk factors in persons living with HIV/AIDS: A meta-analysis. AIDS (London, England), 30(2), 273–291. https://doi.org/10.1097/qad.0000000000000922
   PubMed Web of Science ®Google Scholar
• Powles, T., Thirwell, C., Newsom-Davis, T., Nelson, M., Shah, P., Cox, S., Gazzard, B., & Bower, M. (2003). Does HIV adversely influence the outcome in advanced non-small-cell lung cancer in the era of HAART? British Journal of Cancer, 89(3), 457–459. https://doi.org/10.1038/sj.bjc.6601111
   PubMed Web of Science ®Google Scholar
• Rengan, R., Mitra, N., Liao, K., Armstrong, K., & Vachani, A. (2012). Effect of HIV on survival in patients with non-small-cell lung cancer in the era of highly active antiretroviral therapy: A population-based study. The Lancet Oncology, 13(12), 1203–1209. https://doi.org/10.1016/s1470-2045(12)70466-7
   PubMed Web of Science ®Google Scholar
• Shiels, M. S., Althoff, K. N., Pfeiffer, R. M., Achenbach, C. J., Abraham, A. G., Castilho, J., … Design of the International Epidemiologic Databases to Evaluate, A. (2017). HIV Infection, immunosuppression, and age at diagnosis of non-AIDS-defining cancers. Clinical Infectious Diseases: an Official Publication of the Infectious Diseases Society of America, 64(4), 468–475. https://doi.org/10.1093/cid/ciw764
   PubMed Web of Science ®Google Scholar
• Sigel, K., Crothers, K., Dubrow, R., Krauskopf, K., Jao, J., Sigel, C., Moskowitz, A., & Wisnivesky, J. (2013). Prognosis in HIV-infected patients with non-small cell lung cancer. British Journal of Cancer, 109(7), 1974–1980. https://doi.org/10.1038/bjc.2013.545
   PubMed Web of Science ®Google Scholar
• Sigel, K., Wisnivesky, J., Crothers, K., Gordon, K., Brown, S. T., Rimland, D., Rodriguez-Barradas, M. C., Gibert, C., Goetz, M. B., Bedimo, R., Park, L. S., & Dubrow, R. (2017). Immunological and infectious risk factors for lung cancer in US veterans with HIV: A longitudinal cohort study. The Lancet HIV, 4(2), e67–e73. https://doi.org/10.1016/S2352-3018(16)30215-6
   PubMed Web of Science ®Google Scholar
• Sigel, K., Wisnivesky, J., Gordon, K., Dubrow, R., Justice, A., Brown, S. T., Goulet, J., Butt, A. A., Crystal, S., Rimland, D., Rodriguez-Barradas, M., Gibert, C., Park, L. S., & Crothers, K. (2012). HIV as an independent risk factor for incident lung cancer. AIDS (London, England), 26(8), 1017–1025. https://doi.org/10.1097/QAD.0b013e328352d1ad
   PubMed Web of Science ®Google Scholar
• Suneja, G., Shiels, M. S., Melville, S. K., Williams, M. A., Rengan, R., & Engels, E. A. (2013). Disparities in the treatment and outcomes of lung cancer among HIV-infected individuals. AIDS (London, England), 27(3), 459–468. https://doi.org/10.1097/QAD.0b013e32835ad56e
   PubMed Web of Science ®Google Scholar
• Targeted Cancer Therapies. https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies/targeted-therapies-fact-sheet
   Google Scholar
• Treatment With Immunological Checkpoint Inhibitors of HIV-infected Subjects With Cancer (PembroHIV). (2018). https://clinicaltrials.gov/ct2/show/NCT03767465#contacts
   Google Scholar
• Winstone, T. A., Man, S. F. P., Hull, M., Montaner, J. S., & Sin, D. D. (2013). Epidemic of lung cancer in patients with HIV infection. Chest, 143(2), 305–314. https://doi.org/10.1378/chest.12-1699
   PubMed Web of Science ®Google Scholar
• Zheng, J., Wang, L., Cheng, Z., Pei, Z., Zhang, Z., Li, Z., Zhang, X., Yan, D., Xia, Q., Feng, Y., Song, Y., Chen, W., Zhang, X., Xu, J., & Wang, J. (2018). Molecular changes of lung malignancy in HIV infection. Scientific Reports, 8(1), 13128. https://doi.org/10.1038/s41598-018-31572-6
   PubMedGoogle Scholar